Terapad
Created with the free version of Terapad, ads can be removed from $14.15 a month Easy Website Creation Sign Up Now

Content

UCSB takes role in diabetes drug project

User photo not available Monday, 12 May 08 - 02:19 PM (GMT -08:00)
By Bob Nidever in NEWS_Research

" UC Santa Barbara has joined with drugmaker Pfizer and several institutions to foster research that could lead to better understanding and treatment of diabetes.

"Pfizer is putting up $14 million for the first three years of the project, one of the first of its kind. The project embraces a new approach to research that marks a shift in how university and pharmaceutical researchers work and serves as a model for the future, according to those involved in its creation.

'"We have a program at UCSB that is working very much at the interface of medicine and technology," said Frank Doyle, who is heading the project at the university. "Even in the absence of a medical school, we're able to work on partnerships with Big Pharma that are going to deliver enabling medical technology." [VenturaCountyStar]MORE

Email this  |  Submit to digg  |  Add to del.icio.us  |  Permalink   


Industry, UCSB ties are growing

User photo not available Monday, 24 March 08 - 04:35 PM (GMT -08:00)
By Bob Nidever in NEWS_Research
" SANTA BARBARA — The walls between industry and academe are being scaled in many different ways when it comes to engineering and science at UC Santa Barbara. The relationship is expanding to forge new bonds between the university's resources and research and corporate knowledge and needs.

Ideas from the university reach the market in a variety of ways. Professors at the university have started companies based on their research, and students have created their own companies while in the Technology Management Program.


There has been more than $650 million in venture funding in the past three years for companies with ties to UCSB.

There also are companies that do research at the university or invite university faculty and students into their labs. That's one reason for the corporate affiliates program — to create those partnerships." [VenturaCountyStar] MORE

Email this  |  Submit to digg  |  Add to del.icio.us  |  Permalink   


Building Biomedical - UCI Wants to Place Device Grads in Local Companies

User photo not available Thursday, 18 October 07 - 07:52 AM (GMT -08:00)
By Bob Nidever in NEWS_Research
" The University of California, Irvine’s biomedical engineering department is looking to do more with Orange County’s medical device sector—a prime job market for its graduates.

"The department, particularly its 10-member, industry-heavy advisory board, plans to work on ways to get its graduates to interact more with companies, said Steven George, the 5-year-old department’s chair and its William J. Link professor of biomedical engineering.

"Last month, Edwards gave $5 million to UCI’s Henry Samueli School of Engineering, which includes the biomedical department, to start a research and development center for heart devices. The department will direct the Edwards Lifesciences Center for Advanced Cardiovascular Technology. [OCBJ] MORE
Email this  |  Submit to digg  |  Add to del.icio.us  |  Permalink   


Abraxis BioScience and the CNSI Announce Partnership for Collaborative Research in the Development of New Nanobiotechnologies

User photo not available Friday, 27 July 07 - 09:19 PM (GMT -08:00)
By Bob Nidever in NEWS_Research

 " LOS ANGELES--(BUSINESS WIRE)--Jul 26, 2007 - Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, and the California NanoSystems Institute at UCLA today announced a partnership designed to collaborate on early research in nanobiotechnology for the advancement of new technologies in medicine.

"We are very excited about this research collaboration with the CNSI and believe this type of relationship emphasizes our commitment toward pursuing innovative research and forging new paradigms of drug discovery and personalized drug development," said Patrick Soon-Shiong, M.D., Chairman and Chief Executive Officer of Abraxis BioScience. "This relationship allows both organizations to gain access to important research that may have the potential to change the way diseases are treated."

"We are eager to collaborate with Abraxis BioScience. Cross-disciplinary collaboration is vital to our research efforts," said Dr. Fraser Stoddart, Director of the CNSI and Fred Kavli Chair of NanoSystems Sciences at UCLA. "The exciting thing about nanosystems research is that it is bringing about a sea change in the academic environment - it is breaking down the barriers between disciplines to achieve a seamless integration between chemistry, physics, biology and engineering in all of their different forms."  [PharmaLive] MORE

Email this  |  Submit to digg  |  Add to del.icio.us  |  Permalink   


UC Irvine to Test and Analyze New Plug-in Hybrid Electric Vehicle

User photo not available Friday, 27 July 07 - 09:10 PM (GMT -08:00)
By Bob Nidever in NEWS_Research

 " The Advanced Power and Energy Program at the University of California, Irvine will evaluate a prototype Toyota plug-in hybrid electric vehicle, or PHEV, as part of a nearly $3 million research effort to determine how the widespread use of such technology would affect air quality and the demand for electricity in California.

" 'UCI has been a great research partner for many years, and the research to be conducted on the air quality impacts of plug-in hybrids will be critical in making key development decisions about the technology,' said Dave Illingworth, senior vice president and chief planning officer for Toyota Motor Sales, U.S.A.

“ 'It is very good news that Toyota is now developing pre-commercial plug-in hybrid electric vehicles for this important study,' said John E. Bryson, chairman and chief executive officer of Edison International. “We look forward to having our electric vehicle team join the UCI researchers and Toyota employees in evaluating the impact of plug-in hybrids on the electric grid. The national electric infrastructure is a major resource for enabling future clean transportation.”  [WebWire] MORE

Email this  |  Submit to digg  |  Add to del.icio.us  |  Permalink   


UCSB and IQE Collaboration Achieves Record Breaking HBT

User photo not available Wednesday, 06 June 07 - 10:39 PM (GMT -08:00)
By Bob Nidever in NEWS_Research

 "Steve Gergar, General Manager of IQE’s Pennsylvania operation commented, 'IQE is very pleased to have contributed the epitaxial material upon which UCSB has achieved these exciting InP-DHBT high speed results. We have collaborated extensively with Professor Rodwell’s group for nearly a decade, where many record InP-DHBTs results have been demonstrated over the years. Additionally, we are particularly pleased with the success of these latest results as it shows how both sides have benefited immensely from the interaction. These results affirm IQE’s strength in advanced materials and structures, beyond the typical high quality SHBT and DHBTs we have in standard production. This also confirms our commitment to the R&D community, and we look forward to continued successful collaborations with UCSB and other research groups in the years to come.”  [IQE press release] MORE

Email this  |  Submit to digg  |  Add to del.icio.us  |  Permalink   


UCSD and Jazz Semiconductor Develop 8-Element 6-18 GHz Phased Array Chip with Record Performance

User photo not available Wednesday, 28 March 07 - 06:19 PM (GMT -08:00)
By Bob Nidever in NEWS_Research

 " The University of California, San Diego (UCSD), provider of a leading program in microwave and millimeter-wave RFICs and mixed-signal, and Jazz Semiconductor, a wholly owned subsidiary of Jazz Technologies, Inc. (AMEX:JAZ) and an independent wafer foundry focused primarily on specialty CMOS process technologies, today announced that they have collaborated to develop an 8-element RFIC phased array receiver covering the 6-18 GHz frequency range...  [Businesswire]  MORE

Email this  |  Submit to digg  |  Add to del.icio.us  |  Permalink   


Researchers design pulsed mircrojet system to deliver protein drugs without pain or bruising

User photo not available Tuesday, 06 March 07 - 03:30 PM (GMT -08:00)
By Bob Nidever in NEWS_Research
" Santa Barbara, California – March 6, 2007 -- A team of UCSB researchers, in collaboration with colleagues from UC Berkeley and StrataGent Life Sciences, of Los Gatos, California, has designed a novel pulsed microjet system engineered to deliver protein drugs into the skin without the pain or bruising that deeper penetration injection systems cause. The research was published online today in the Proceedings of the National Academy of Sciences...  MORE [EurekAlert!]
Email this  |  Submit to digg  |  Add to del.icio.us  |  Permalink   


UCSB Launches New Solid State Lighting and Energy Center

User photo not available Sunday, 25 February 07 - 11:25 PM (GMT -08:00)
By Bob Nidever in NEWS_Research
Second Generation Center Broadens Focus to Include Clean Energy and Energy Efficiency to Reduce Global Warming - Mitsubishi Chemical Corporation First to Join New Center

" The College of Engineering at UC Santa Barbara is formally launching the Solid State Lighting and Energy Center (SSLEC) March 1, 2007, directed by Shuji Nakamura, Cree Professor in Solid State Lighting and Displays, and Steven DenBaars, Mitsubishi Chemical Professor in Solid State Lighting and Displays. The SSLEC, the second generation of UCSB’s original Solid State Lighting Center, is broadening its scope to include new research interests, including clean energy and energy efficiency, critical to reducing global warming.

" Mitsubishi Chemical Corporation, of Tokyo, Japan, is the first industrial member to join SSLEC, giving $2.5 million over the next six years to support the Center and its research. SSLEC members will participate in the research program and have access to certain intellectual property developed at the SSLEC...
  [ucsb]  MORE
Email this  |  Submit to digg  |  Add to del.icio.us  |  Permalink   


... More items are available in my News Archive